AlphaYouBC
Insider buying
Bain Capital Life Sciences Investors, Llc bought $25M of Kailera Therapeutics, Inc. (KLRA) stock
Bain Capital Life Sciences Investors, Llc, 10% owner of Kailera Therapeutics, Inc. (KLRA), bought 1,562,500 shares of KLRA stock worth $25M, per an SEC Form 4 filed Apr 20, 2026.
It was an open-market purchase.
The trade was reported on Apr 20, 2026.
KLRA has moved -47.9% since the trade date, from $24.61 to $12.83 (Sep 18, 2026 close).
- Traded
- Apr 20, 2026
- Disclosed
- Apr 20, 2026
- Filing delay
- 0 days
- Price since
- -47.9%
- Role
- 10% owner
- Source
- SEC Form 4
More KLRA insider and Congress trades
From a public SEC Form 4, linked above. Not investment advice, and not a recommendation to buy or sell.